AZD7760 for staphylococcal infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Dec 2024: Trial registered, NCT06749457
  2. 30 Dec 2024: Trial started, NCT06749457

The trials

NCT06749457: A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

State
Under way
Phase
Phase 1 and Phase 2
People
242 taking part
Started
30 Dec 2024
Primary completion
8 Mar 2027
Arms
Phase I: AZD7760 Dose A, Phase I: AZD7760 Dose B, Phase I: AZD7760 Dose C, Phase IIa: AZD7760 Dose D and Placebo, Phase IIa: AZD7760 Dose E
Results
None posted
  1. 27 Dec 2024: Trial registered
  2. 30 Dec 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.